Corcept Therapeutics | CORT - Lucro Bruto Sobre Vendas





Lucro Bruto Sobre Vendas Alterar Data
Acadia Pharmaceuticals USD 279.64M 36.37M 2026-06
Alaunos Therapeutics USD -1.13M 1.11M 2024-09
ANI Pharmaceuticals USD 143.88M 19.7M 2026-03
Ardelyx USD 89.66M 24.7M 2026-03
Aurora Cannabis CAD 29.79M 16.83M 2026-03
BioMarin Pharmaceutical USD 713.42M 142.21M 2026-06
Bristol-Myers Squibb USD 9.26B 1.19B 2026-06
Canopy Growth CAD 8.26M 13.2M 2026-03
Corcept Therapeutics USD 252.09M 90.07M 2026-06
Eli Lilly USD 16.22B 301.7M 2026-03
J&J USD 18.55B 1.31B 2026-06
Knight Therapeutics CAD 64.72M 8.91M 2025-12
Lexicon Pharmaceuticals USD 5.29M 8.88M 2025-12
Merck USD 12.09B 1.24B 2026-03
Nektar Therapeutics USD 10.86M 10.95M 2026-03
Novartis USD 11.24B 1.18B 2026-06
Novartis USD 10.07B 758M 2026-03
Omeros USD -33.16M 18.52M 2024-06
Pacira USD 133.91M 7.27M 2026-06
Pfizer USD -248M 11.29B 2026-06
Supernus Pharmaceuticals USD 160.06M 30.7M 2026-06
TG Therapeutics USD 199.14M 27.73M 2026-06